Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Increased mortality with FLA compared with ADE chemotherapy in high-risk AML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Increased mortality with FLA compared with ADE chemotherapy in high-risk AML.
Lane SW, Marlton P, Mollee PN. Increased mortality with FLA compared with ADE chemotherapy in high-risk AML. Blood. 2006 Dec 01; 108(12):3950-1; author reply 3951.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Cytarabine
Daunorubicin
Disease-Free Survival
Etoposide
Female
Humans
Leukemia, Myeloid, Acute
Male
Middle Aged
Remission Induction
Retrospective Studies
Risk Factors
Survival Rate
Treatment Outcome